Skip to main content
. 2019 Nov 29;10(5):928–945. doi: 10.1016/j.apsb.2019.11.014

Table 8.

Pharmacokinetic parameters of transdermal and i.v. administrations (n = 6).

Formulation Tmax (h) Cmax (ng/mL) AUC (h·ng/mL) MRT (h)
1-AACONH2 3.30 ± 1.10 780.54 ± 126.94 10,180.83 ± 2619.01 9.99 ± 0.70
3-AACONH2 4.75 ± 2.22 682.69 ± 124.16 6942.08 ± 1113.59 10.13 ± 0.44
5-AACONH2 3.50 ± 0.58 522.61 ± 113.76 6528.83 ± 1681.43 9.96 ± 1.63
7-AACONH2 5.17 ± 2.23 217.74 ± 49.37 3379.14 ± 835.90 11.53 ± 1.07
i.v. 6893.56 ± 457.45 1.64 ± 0.12

–Not applicable.